Posted by Michael Wonder on 09 Jun 2023
Considering tomorrow’s patients in today’s drug approvals
8 June 2023 - Responding to pressure from patients seeking access to promising new medicines, drug regulatory agencies have worked over several decades to adopt more patient centred approaches.
The decision whether to approve a drug reflects both scientific evidence and value judgments about the sufficiency of that evidence.
